Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab.
Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab.
复制标题
DOI:
10.1007/s13555-021-00672-z
复制
发表时间:
2022-03
影响因子:
3.4
通讯作者:
Tivadar S
中科院分区:
文献类型:
--
作者:
Gkalpakiotis S;Fridman M;Tivadar S
Psoriasis vulgaris is a chronic immune-mediated inflammatory disease of the skin. Biologic therapy has been available for more than 10 years and has become one of the standard treatments for patients with moderate to severe psoriasis. Initially, only biologics against tumour necrosis factor alpha (TNF-α) were used, and only later did drugs against different interleukins (ILs), including IL-17 or IL-23, became available. The side effects of biologic therapy include paradoxical adverse events (PAEs), such as palmoplantar pustular reaction, especially with anti-TNF-α drugs. We present the case of a 49-year-old female patient with diabetes and psoriasis and psoriatic arthritis treated with an adalimumab biosimilar who developed a severe PAE of the palmoplantar pustular type. Treatment with adalimumab was stopped and the patient switched to ixekizumab which was successful. When a paradoxical reaction develops during biologic therapy, especially when it is severe as in our patient, switching to another class of biologics is advised.
登录
查看更多内容
影响因子:
--
作者:
Ma, Hak-Ling;Napierata, Lee;Young, Deborah A.
通讯作者:
Young, Deborah A.
影响因子:
24.5
作者:
Tillack, Cornelia;Ehmann, Laura Maximiliane;Brand, Stephan
通讯作者:
Brand, Stephan
影响因子:
105.7
作者:
Parisi, Rosa;Iskandar, Ireny Y. K.;Ashcroft, Darren M.
通讯作者:
Ashcroft, Darren M.
DOI:
10.1159/000479475
发表时间:
2018-01-01
期刊:
Current problems in dermatology
影响因子:
--
作者:
Puig, Lluis
通讯作者:
Puig, Lluis
影响因子:
3.4
作者:
Armstrong AW;Soliman AM;Betts KA;Wang Y;Gao Y;Puig L;Augustin M
通讯作者:
Augustin M